Literature DB >> 2836685

Short-term changes in hepatic HMG-CoA reductase in rats fed diets containing cholesterol or oat bran.

M J Kelley1, J A Story.   

Abstract

In vivo regulation of hepatic HMG-CoA reductase (HMGR) (mevalonate:NADP+ oxidoreductase [acylating CoA]; EC 1.1.1.34] by phosphorylation/dephosphorylation has not been demonstrated. Rats were meal-fed semipurified diets; effects of inclusion of cholesterol (2%) or oat bran (15%) in a single meal on expressed (phosphorylated) and total (dephosphorylated) activities of HMGR were measured from 15 min to 4 hr after presentation of the meal. Expressed activity was not significantly altered in response to the control diet during the time periods examined, while total HMGR activity declined by 15 min and increased through 4 hr to an activity about 1.5 times control levels. Addition of cholesterol resulted in little change in expressed activity but a greater and more sustained reduction in total activity. Oat bran caused reductions in both total and expressed activities, which were maintained through 4 hr. Total HMGR activity was best correlated with apparent demand for cholesterol synthesis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2836685     DOI: 10.1007/BF02536451

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  10 in total

1.  Interconversion of active and inactive forms of rat liver hydroxymethylglutaryl-CoA reductase.

Authors:  J L Nordstrom; V W Rodwell; J J Mitschelen
Journal:  J Biol Chem       Date:  1977-12-25       Impact factor: 5.157

2.  Active and inactive forms of 3-hydroxy-3-methylglutaryl coenzyme A reductase in the liver of the rat. Comparison with the rate of cholesterol synthesis in different physiological states.

Authors:  M S Brown; J L Goldstein; J M Dietschy
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

3.  Factors affecting the diurnal variation in the level of -hydroxy- -methylglutaryl coenzyme A reductase and cholesterol-synthesizing activity in rat liver.

Authors:  R E Dugan; L L Slakey; A V Briedis; J W Porter
Journal:  Arch Biochem Biophys       Date:  1972-09       Impact factor: 4.013

Review 4.  Regulation of HMG-CoA reductase.

Authors:  V W Rodwell; J L Nordstrom; J J Mitschelen
Journal:  Adv Lipid Res       Date:  1976

5.  Modulation of hydroxymethylglutaryl-CoA reductase activity, reductase kinase activity, and cholesterol synthesis in rat hepatocytes in response to insulin and glucagon.

Authors:  T S Ingebritsen; M J Geelen; R A Parker; K J Evenson; D M Gibson
Journal:  J Biol Chem       Date:  1979-10-25       Impact factor: 5.157

6.  Reversible modulation of the activities of both liver microsomal hydroxymethylglutaryl coenzyme A reductase and its inactivating enzyme. Evidence for regulation by phosphorylation-dephosphorylation.

Authors:  T S Ingebritsen; H S Lee; R A Parker; D M Gibson
Journal:  Biochem Biophys Res Commun       Date:  1978-04-28       Impact factor: 3.575

7.  The in vivo regulation of rat liver 3-hydroxy-3-methylglutaryl coenzyme A reductase. Phosphorylation of the enzyme as an early regulatory response following cholesterol feeding.

Authors:  R E Arebalo; J E Hardgrave; T J Scallen
Journal:  J Biol Chem       Date:  1981-01-25       Impact factor: 5.157

8.  The structure of an inhibitor of cholesterol biosynthesis isolated from barley.

Authors:  A A Qureshi; W C Burger; D M Peterson; C E Elson
Journal:  J Biol Chem       Date:  1986-08-15       Impact factor: 5.157

9.  Hypocholesterolemic effects of oat-bran or bean intake for hypercholesterolemic men.

Authors:  J W Anderson; L Story; B Sieling; W J Chen; M S Petro; J Story
Journal:  Am J Clin Nutr       Date:  1984-12       Impact factor: 7.045

10.  Oat-bran intake selectively lowers serum low-density lipoprotein cholesterol concentrations of hypercholesterolemic men.

Authors:  R W Kirby; J W Anderson; B Sieling; E D Rees; W J Chen; R E Miller; R M Kay
Journal:  Am J Clin Nutr       Date:  1981-05       Impact factor: 7.045

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.